Diabetes and Vascular Disease Research
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.1 | Q2 | 65.0% | 0.907 | Q2 | 81.2% |
| 2024 | 3.0 | Q2 | 68.7% | 1.122 | Q1 | 87.0% |
| 2023 | 2.8 | Q2 | 65.3% | 0.796 | Q2 | 79.6% |
| 2022 | 2.4 | Q3 | 50.0% | 0.775 | Q2 | 79.7% |
| 2021 | 3.5 | Q3 | 62.3% | 0.781 | Q2 | 80.5% |
| 2020 | — | — | 0.965 | Q2 | 84.6% | |
| 2019 | — | — | 0.934 | Q2 | 84.1% | |
| 2018 | — | — | 1.043 | Q1 | 85.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1752-8984
ISSN
1479-1641
region
Western Europe
coverage
2004-2026